VistaGen Therapeutics, Inc. (VSTA) Progress in the Labs Enable Advanced Tools for Drug Rescue and Potential Cell Therapies
VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, earlier today announced significant advancements in its stem cell technology licensed from the University Health Network (UHN) in Toronto, Canada. The advancements improve the company’s ability to develop new stem cell-based bioassay systems and potentially improved cell therapies for human blood system disorders. “In collaboration with our long-term strategic partners at UHN, we continue to pioneer stem cell technology that promises to change the way we develop medicine and apply treatment,” stated Shawn K. Singh, CEO of VistaGen. “In addition to creating…